Articles dans des revues avec comité de lecture (400)
33.
Syed, F., Tersey, S. S., Turatsinze, J. V., Felton, J. J., Kang, N. J., Nelson, J. J., Sims, E. E., Defrance, M., Bizet, M., Fuks, F., Cnop, M., Bugliani, M., Marchetti, P., Ziegler, A. G., Bonifacio, E., Webb-Robertson, B. J. B., Balamurugan, A. A., Evans-Molina, C., Eizirik, D. L., Mather, K. K., Arslanian, S., & Mirmira, R. R. (2020). Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes. Clinical Epigenetics, 12(1), 116. doi:10.1186/s13148-020-00906-534.
Marselli, L., Piron, A., Suleiman, M., Colli, M. L., Yi, X., Khamis, A., Carrat, G., Rutter, G. A., Bugliani, M., Giusti, L., Ronci, M., Ibberson, M., Turatsinze, J. V., Boggi, U., De Simone, P., De Tata, V., Lopes, M., Nasteska, D., De Luca, C., Tesi, M., Bosi, E., Singh, P., Campani, D., Schulte, A. M., Solimena, M., Hecht, P., Rady, B., Bakaj, I., Pocai, A., Norquay, L., Thorens, B., Canouil, M., Froguel, P., Eizirik, D. L., Cnop, M., & Marchetti, P. (2020). Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes. Cell reports, 33(9), 108466. doi:10.1016/j.celrep.2020.10846637.
Coomans De Brachene, A., Castela, A., Op De Beeck, A., Mirmira, R. R., Marselli, L., Marchetti, P., Masse, C., Miao, W., Leit, S., Evans-Molina, C., & Eizirik, D. L. (2020). Pre‐clinical evaluation of TYK2 inhibitors for human beta cell protection in type 1 diabetes. Diabetes, obesity and metabolism. doi:10.1111/dom.1410438.
Zhang, J., Chen, L., Wang, F., Zou, Y., Li, J., Luo, J., Khan, F., Sun, F., Li, Y., Liu, J., Chen, Z., Zhang, S., Xiong, F., Yu, Q., Li, J., Huang, K., Adam, B.-L., Zhou, Z., Eizirik, D. L., Yang, P., & Wang, C. Y. (2020). Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability. Diabetologia, 63(5), 987-1001. doi:10.1007/s00125-020-05105-839.
Colli, M. L., Ramos-Rodríguez, M., Nakayasu, E. S., Alvelos, M. I., Lopes, M., Hill, J. L. E., Turatsinze, J. V., Coomans De Brachene, A., Russell, M. M., Raurell-Vila, H., Castela, A., Juan-Mateu, J., Webb-Robertson, B.-J. M., Krogvold, L., Dahl-Jorgensen, K., Marselli, L., Marchetti, P., Richardson, S. J., Morgan, N. G., Metz, T. O., Pasquali, L., & Eizirik, D. L. (2020). An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells. Nature communications, 11(1), 2584. doi:10.1038/s41467-020-16327-040.
Nakayasu, E. S., Syed, F., Tersey, S. S., Gritsenko, M., Mitchell, H., Chan, C. Y., Dirice, E., Turatsinze, J. V., Cui, Y., Kulkarni, R., Eizirik, D. L., Qian, W. J., Webb-Robertson, B.-J. M., Evans-Molina, C., Mirmira, R. R., & Metz, T. O. (2020). Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention. Cell Metabolism, 31(2), 363-374.e6. doi:10.1016/j.cmet.2019.12.00541.
Demine, S., Schiavo, A. A., Marin Canas, S., Marchetti, P., Cnop, M., & Eizirik, D. L. (2020). Pro-inflammatory cytokines induce cell death, inflammatory responses, and endoplasmic reticulum stress in human iPSC-derived beta cells. Stem cell research & therapy, 11(1), 7. doi:10.1186/s13287-019-1523-342.
Li, N., Zhang, S., Xiong, F., Eizirik, D. L., & Wang, C. Y. (2020). SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells. Seminars in cell & developmental biology. doi:10.1016/j.semcdb.2020.03.00843.
Wang, F., Sun, F., Luo, J., Yue, T., Chen, L., Zhou, H., Zhang, J., Yang, C., Luo, X., Zhou, Q., Zhu, H., Li, J., Yang, P., Xiong, F., Yu, Q., Zhang, H., Zhang, W., Xu, A., Zhou, Z., Lu, Q., Eizirik, D. L., Zhang, S., & Wang, C. Y. (2019). Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization. Cell death and disease, 10(12), 892. doi:10.1038/s41419-019-2130-z